You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Differentiated metastatic thyroid cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Differentiated Thyroid Cancer Trial in Shanghai (surufatinib)

Recruiting
  • Differentiated Thyroid Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 9, 2023

Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Trial in Beijing (Anlotinib Hydrochloride

Not yet recruiting
  • Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
  • Anlotinib Hydrochloride Capsule and Penpulimab
  • Beijing, Beijing, China
    YansongLin
Sep 25, 2023

Thyroid Cancer Trial in Medellin (Traditional neck dissection approach, Anterior neck dissection approach)

Recruiting
  • Thyroid Cancer
  • Traditional neck dissection approach
  • Anterior neck dissection approach
  • Medellin, Antioquia, Colombia
    Hospital Alma Mater de Antioquia
Nov 20, 2023

Locally Advanced or Metastatic Radioiodine-Refractory

Recruiting
  • Thyroid Neoplasms
  • Anlotinib Hydrochloride Capsule
  • Beijing, Beijing, China
  • +2 more
Aug 9, 2023

Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic

Active, not recruiting
  • Columnar Cell Variant Thyroid Gland Papillary Carcinoma
  • +25 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Torrance, California
  • +6 more
Jan 12, 2023

Thyroglobulin Point of Care Assay for Rapid Detection of

Recruiting
  • Differentiated Thyroid Cancer
  • Lymph Node Metastases
  • Point of care assay for thyroglobulin (POC-Tg) evaluation of a suspected cervical lymph node
  • Ashkelon, Israel
  • +2 more
Oct 25, 2022

BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma Trial in Portland (Binimetinib,

Recruiting
  • BRAF NP_004324.2:p.V600M
  • +6 more
  • Portland, Oregon
    Providence Portland Medical Center
Aug 17, 2022

DTC - Differentiated Thyroid Cancer Trial in Beijing (Anlotinib HCl)

Recruiting
  • DTC - Differentiated Thyroid Cancer
  • Anlotinib hydrochloride
  • Beijing, China
    Peking Union Medical College Hospital
Jan 18, 2022

Thyroid Cancer Trial in Peking (Apatinib)

Completed
  • Thyroid Cancer
  • Peking, China
    Peking Union Medical College Hospital
Jan 18, 2022

Thyroid Tumors Trial in India (Lenvatinib)

Active, not recruiting
  • Thyroid Neoplasms
  • New Delhi, Delhi, India
  • +10 more
Jul 15, 2022

Metastatic Differentiated Thyroid Cancer Trial in Negrar, Milan (Radioiodine optimized therapy)

Recruiting
  • Metastatic Differentiated Thyroid Cancer
  • Radioiodine optimized therapy
  • Negrar, Verona, Italy
  • +1 more
Mar 18, 2022

Differentiated Thyroid Cancer Trial in Philadelphia (Everolimus, Sorafenib)

Active, not recruiting
  • Differentiated Thyroid Cancer
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Oct 18, 2021

Thyroid Cancer Metastatic Trial in France (Lenvatinib + Denosumab)

Recruiting
  • Thyroid Cancer Metastatic
  • Lenvatinib + Denosumab
  • Angers, France
  • +13 more
Mar 14, 2022

Thyroid Cancer Trial in Philadelphia (Lenvatinib, Everolimus)

Suspended
  • Thyroid Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 7, 2021

Thyroid Cancer Trial in Beijing (Anlotinib HCl, Sodium Iodide I 131, Penpulimab)

Recruiting
  • Thyroid Cancer
  • Anlotinib hydrochloride
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Jan 18, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Differentiated Thyroid Cancer Trial in Nanjing, Peking (Apatinib Oral Tablet, Placebo Oral Tablet)

Active, not recruiting
  • Differentiated Thyroid Cancer
  • Apatinib Oral Tablet
  • Placebo Oral Tablet
  • Nanjing, Jiangsu, China
  • +1 more
Aug 9, 2021

Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation Trial in Villejuif (Trametinib,

Active, not recruiting
  • Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
  • Villejuif, Val De Marne, France
    Gustave Roussy
Sep 27, 2021

Differentiated Thyroid Cancer Trial in Worldwide (Dabrafenib, Trametinib, Trametinib )

Recruiting
  • Differentiated Thyroid Cancer
  • Caba, Buenos Aires, Argentina
  • +41 more
Nov 25, 2022

Differentiated Thyroid Cancer Trial in Beijing (124I PET/CT)

Recruiting
  • Differentiated Thyroid Cancer
  • 124I PET/CT
  • Beijing, Beijing, China
  • +1 more
May 6, 2021

Metastatic Thyroid Gland Carcinoma, Poorly Differentiated Thyroid Gland Carcinoma, Thyroid Gland Anaplastic Carcinoma by AJCC V8

Suspended
  • Metastatic Thyroid Gland Carcinoma
  • +2 more
  • Saint Petersburg, Russian Federation
    Saint-Petersburg State University (SPSU) N.I.Pirogov Clinic of H
May 13, 2021

Differentiated Thyroid Cancer Patients Treated With Different

Not yet recruiting
  • Thyroid Cancer
  • (no location specified)
Nov 15, 2023

Efficacy of Lenvatinib in Differentiated Thyroid Cancer

Recruiting
  • Differentiated Thyroid Cancer
  • Gender
  • Rome, Italy
    Regina Elena National Cancer Institute
Mar 16, 2023

Thyroid Cancer Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (drug, radiation,

Recruiting
  • Thyroid Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 28, 2023

Recurrence in Patients With Differentiated Thyroid Cancer

Not yet recruiting
  • Differentiated Thyroid Cancer
  • (no location specified)
Nov 30, 2023